Lv11
40 积分 2023-07-03 加入
A comprehensive review of immune checkpoint inhibitors for cancer treatment
1个月前
已完结
CD19: a promising target for systemic sclerosis
1个月前
已完结
Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management
3个月前
已完结
Antitumor activity of a ROR1 × CD3 bispecific antibody in non-small cell lung cancer
3个月前
已完结
Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial
4个月前
已完结
Efficacy and Safety of the Anti–PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study
4个月前
已完结
[Chinese guideline for diagnosis and management of drug-induced liver injury (2023 version)]
5个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
5个月前
已完结
Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO‐AML trials
5个月前
已完结
Long-term results in children with AML: NOPHO-AML Study Group – report of three consecutive trials
5个月前
已完结
皖公网安备34019202002308
